These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37260420)

  • 1. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.
    Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS
    Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris.
    Schinner J; Cunha T; Mayer JU; Hörster S; Kind P; Didona D; Keber C; Hertl M; Worzfeld T; Juratli HA
    Front Immunol; 2023; 14():1203776. PubMed ID: 37415985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease.
    Morais KL; Miyamoto D; Orfali RL; Maruta CW; Santi CG; Sotto MN; da Silva LFF; Branco ACCC; Sato MN; Aoki V
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2890-2897. PubMed ID: 32531145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.
    Rico MJ; Benning C; Weingart ES; Streilein RD; Hall RP
    Br J Dermatol; 1999 Jun; 140(6):1079-86. PubMed ID: 10354074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-31 and IL-31 receptor alpha in pemphigus: Contributors to more than just itch?
    Okuno S; Hashimoto T; Yamazaki Y; Okuzawa M; Satoh T
    J Dermatol; 2023 Jul; 50(7):927-930. PubMed ID: 36651089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible interaction between periostin and CD163
    Fujimura T; Kakizaki A; Furudate S; Aiba S
    Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions.
    Sun XK; Chen JF; Shen H
    Arch Dermatol Res; 2016 Aug; 308(6):429-36. PubMed ID: 27221282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cells in pemphigus vulgaris and bullous Pemphigoid: From pathogenic roles to targeting therapies.
    Yuan Q; Yang W; Zhang X
    Int Immunopharmacol; 2023 Oct; 123():110694. PubMed ID: 37523970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris.
    Ernst N; Friedrich M; Bieber K; Kasperkiewicz M; Gross N; Sadik CD; Zillikens D; Schmidt E; Ludwig RJ; Hartmann K
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):486-492. PubMed ID: 32596926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid.
    Hu Z; Zheng M; Guo Z; Zhou W; Zhou W; Yao N; Zhang G; Lu Q; Zhao M
    Clin Immunol; 2024 Jun; 263():110219. PubMed ID: 38631594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
    Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
    Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid.
    Han Z; Fan Y; Wu Q; Guo F; Li S; Hu X; Zuo YG
    Int Immunopharmacol; 2024 Feb; 128():111470. PubMed ID: 38185033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid.
    Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Aiba S
    Dermatology; 2014; 229(4):369-78. PubMed ID: 25401296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.
    Żebrowska A; Woźniacka A; Juczyńska K; Ociepa K; Waszczykowska E; Szymczak I; Pawliczak R
    Mediators Inflamm; 2017; 2017():8980534. PubMed ID: 28611508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
    Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
    Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.
    Kowalski EH; Kneibner D; Kridin K; Amber KT
    Autoimmun Rev; 2019 May; 18(5):526-534. PubMed ID: 30844553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
    Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
    Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.